The FDA-approved Thermo Scientific Spot-Light HER2 CISH Kit is designed to allow users to perform an HER2 assay analogous to routine immunohistochemistry (IHC) that provides reliable gene status information and improves on the results obtained by fluorescent in situ hybridisation (FISH).
Current FDA-approved HER2 evaluation processes for screening breast cancer patients likely to respond to Herceptin therapy are FISH and IHC. The kit is claimed to have advantages to both of these methods.
Phone: 1800 331 627
Takara Bio PrimeCap T7 RNA Polymerase (low dsRNA)
The polymerase is designed to remove both the technical and financial barriers to the successful...
Maxwell Biosystems MaxTwo high-density microelectrode array (HD-MEA) system
The next-generation multiwell HD-MEA captures high-quality signals at subcellular resolution from...
Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit
The kit includes a comprehensive set of optimised screening reagents and conditions that...
